Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
87.23
-2.39 (-2.67%)
At close: Nov 6, 2026, 4:00 PM EST
87.77
+0.54 (0.62%)
After-hours: Nov 6, 2026, 5:43 PM EST

Merit Medical Systems Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6111,5161,3571,2571,1511,075
Revenue Growth
9.06%11.75%7.89%9.24%7.09%11.50%
Gross Profit
789.05738.27643.33583.87519.1485.33
Operating Income
223.83193.9168.04135.07108.2684.4
Net Income
160.12128.49120.3694.4174.5248.45
Earnings Per Share
2.672.132.031.621.290.84
EPS Growth
36.89%4.93%25.31%25.58%53.57%-

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Peripheral Intervention
-579.84532.77502.22439.81405.12
Cardiac Intervention
-448.91368.95358.45343.19320.64
Custom Procedural Solutions
-209.33200.03195.33190.19193.94
OEM
-204.96199.99164.56145.03123.53
Endoscopy
-72.8654.7736.8132.7631.52
Revenue (Total)
1,6111,5161,3571,2571,1511,075

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
503.55446.4376.72588.5458.4167.75
Total Debt
822.06821.57794.67891.36268.75316.48
Net Cash (Debt)
-318.51-375.17-417.95-302.82-210.34-248.73
Net Cash Growth
------
Net Cash Per Share
-5.30-6.21-7.04-5.19-3.65-4.34

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
273.74297.37220.8145.15114.29147.23
Capital Expenditures
-70.15-81.72-35.14-34.29-45.03-27.94
Free Cash Flow
203.59215.66185.66110.8669.26119.29
Free Cash Flow Growth
-1.59%16.16%67.47%60.06%-41.94%0.01%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
48.98%48.70%47.42%46.44%45.10%45.16%
Operating Margin
13.89%12.79%12.39%10.74%9.41%7.85%
Pretax Margin
13.14%11.28%11.06%8.91%7.18%5.02%
Profit Margin
9.94%8.48%8.87%7.51%6.47%4.51%
FCF Margin
12.64%14.23%13.69%8.82%6.02%11.10%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
32.6640.6746.8346.4653.9472.59
Forward PE
19.4122.5127.1324.0425.9727.70
P/FCF Ratio
25.6724.2330.3639.5758.0429.49
PS Ratio
3.243.454.163.493.493.27